发明名称 |
NOVEL 1,2-DIHYDROQUINOLINE DERIVATIVE HAVING SUBSTITUTED PHENYLAMINO LOWER ALKYL GROUP AND ESTER-INTRODUCED PHENYL GROUP AS SUBSTITUENTS |
摘要 |
Disclosed is a novel 1,2-dihydroquinoline derivative represented by the g eneral formula (1) below, which has a substituted phenylamino lower alkyl gr oup and a phenyl group having an ester structure introduced therein as subst ituents, or a salt of such a derivative. The compound (1) or a salt thereof is useful as a glucocorticoid receptor modulator. In the formula below, R1 r epresents a hydrogen atom or a lower alkyl group; R2 represents a hydrogen a tom or a lower alkyl group; R3 and R4 may be the same or different and repre sent a hydrogen atom or a lower alkyl group; R5 represents a hydrogen atom o r a lower alkyl group; R6 represents a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a nitro group or a cyano group; X repre sents -C(O)-, -C(O)NR8-, -S(O)2- or the like; R7 and/or R8 may be the same o r different and represent a hydrogen atom, an optionally substituted lower a lkyl group, an optionally substituted aryl group, an optionally substituted heterocyclic group, an optionally substituted lower alkoxy group or the like ; Y represents a lower alkylene group; and p represents 0, 1, 2 or 3.</SDOAB >
|
申请公布号 |
CA2668596(A1) |
申请公布日期 |
2008.05.22 |
申请号 |
CA20072668596 |
申请日期 |
2007.11.14 |
申请人 |
SANTEN PHARMACEUTICAL CO., LTD. |
发明人 |
TAKAI, MIWA;KOBAYASHI, SACHIKO;KATO, MASATOMO;MORI, TOSHIYUKI;NAGATSUKA, MASATO;MATSUDA, MAMORU |
分类号 |
C07D215/14;A61K31/47;A61K31/4709;A61P1/04;A61P3/04;A61P3/06;A61P3/10;A61P3/14;A61P5/00;A61P9/00;A61P9/12;A61P11/00;A61P11/02;A61P11/06;A61P17/00;A61P25/00;A61P25/18;A61P25/28;A61P27/06;A61P37/00;A61P37/06;A61P37/08;A61P43/00;C07D311/80;C07D401/12;C07D405/12;C07D409/12;C07D413/12;C07D417/12;C07D491/052 |
主分类号 |
C07D215/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|